Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation. More
Rabbit polyclonal antibodies that recognize the human and mouse S100A15 proteins More
Hexabrix, the contrast material used in the study thus far, has also proven to be effective for atopic dermatitis/eczema in a mouse model and for allergic conjunctivitis in a rat model. More
Antimicrobial Peptide More
Bio-mimicking (3D cell culture) research tools for drug development More
Device and Consumables for Measuring Blood Product Degradation More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2012 - 1350 pages - $2,695
Nov 2010 - 27 pages - $750
Oct 2009 - 30 pages - $995
Mar 2011 - 23 pages - $750
Mar 2011 - 5 pages - $500
Dec 2011 - 50 pages - $3,800
Mar 2011 - 21 pages - $750
Jan 2012 - 30 pages - $250
Nov 2008 - 88 pages - $3,800
Jan 2011 - 130 pages - $3,835
Your selection
Browse By
- Industry sector
- Biological materials
- Reagents
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us